Tumor-derived exosomes: Potential biomarkers and therapeutic target in the treatment of colorectal cancer

J Cell Physiol. 2019 Aug;234(8):12422-12432. doi: 10.1002/jcp.28080. Epub 2019 Jan 13.

Abstract

Colorectal cancer (CRC) is the third most common cause of cancer-related death in men and women in many countries. Early detection of CRC helps to prevent the advanced stages of the disease, and may thereby improve the survival of these patients. A noninvasive test with high specificity and sensitivity is required for this. Exosomes are lipid bilayer membrane nanovesicles that are released into most body fluids and especially in the microenvironment of cancer. They carry various proteins, lipids, and nucleic materials such as DNA, RNA, messenger RNA (mRNA), and microRNA (miRNA), and may also alter the function of target cells. In this review, we aimed to describe the biogenesis, composition, function, and the role of tumor-derived exosomes in cancer progression. Moreover, their applications in tumor diagnosis and treatment are described, with a particular focus on CRC.

Keywords: biomarkers; colorectal cancer; diagnosis; exosomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / pathology*
  • DNA, Neoplasm / genetics
  • Disease Progression
  • Drug Delivery Systems / methods
  • Early Detection of Cancer
  • Exosomes / genetics
  • Exosomes / metabolism*
  • Humans
  • MicroRNAs / genetics
  • RNA, Neoplasm / genetics
  • Tumor Microenvironment

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • MicroRNAs
  • RNA, Neoplasm